| Product Code: ETC9556153 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import of gram-positive bacterial infection treatments in Sweden saw a notable growth rate of 17.67% in 2024, indicating a rising demand for such products. The top exporting countries to Sweden in this sector were Denmark, Belgium, Germany, Netherlands, and Italy. The market concentration, as measured by the HHI, remained low in 2024, suggesting a diverse range of sources for these imports. With a steady compound annual growth rate (CAGR) of 4.63% from 2020 to 2024, the market for gram-positive bacterial infection treatments in Sweden appears to be on a positive trajectory.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Gram-positive Bacterial Infections Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Gram-positive Bacterial Infections Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Gram-positive Bacterial Infections Market - Industry Life Cycle |
3.4 Sweden Gram-positive Bacterial Infections Market - Porter's Five Forces |
3.5 Sweden Gram-positive Bacterial Infections Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Sweden Gram-positive Bacterial Infections Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.7 Sweden Gram-positive Bacterial Infections Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Sweden Gram-positive Bacterial Infections Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Sweden Gram-positive Bacterial Infections Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gram-positive bacterial infections in Sweden |
4.2.2 Rising awareness about the importance of early detection and treatment of bacterial infections |
4.2.3 Technological advancements leading to more effective diagnostic tools and treatment options |
4.3 Market Restraints |
4.3.1 Growing resistance of gram-positive bacteria to antibiotics |
4.3.2 High cost associated with the development and commercialization of new treatment options |
4.3.3 Stringent regulatory requirements for approval of new drugs and therapies |
5 Sweden Gram-positive Bacterial Infections Market Trends |
6 Sweden Gram-positive Bacterial Infections Market, By Types |
6.1 Sweden Gram-positive Bacterial Infections Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Gram-positive Bacterial Infections Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Sweden Gram-positive Bacterial Infections Market Revenues & Volume, By Antibiotic, 2021- 2031F |
6.1.4 Sweden Gram-positive Bacterial Infections Market Revenues & Volume, By Antifungal, 2021- 2031F |
6.1.5 Sweden Gram-positive Bacterial Infections Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Sweden Gram-positive Bacterial Infections Market, By Disease |
6.2.1 Overview and Analysis |
6.2.2 Sweden Gram-positive Bacterial Infections Market Revenues & Volume, By MRSA, 2021- 2031F |
6.2.3 Sweden Gram-positive Bacterial Infections Market Revenues & Volume, By Pneumonia, 2021- 2031F |
6.2.4 Sweden Gram-positive Bacterial Infections Market Revenues & Volume, By Sepsis, 2021- 2031F |
6.2.5 Sweden Gram-positive Bacterial Infections Market Revenues & Volume, By Sinusitis, 2021- 2031F |
6.2.6 Sweden Gram-positive Bacterial Infections Market Revenues & Volume, By Cellulitis, 2021- 2031F |
6.2.7 Sweden Gram-positive Bacterial Infections Market Revenues & Volume, By Otitis, 2021- 2031F |
6.3 Sweden Gram-positive Bacterial Infections Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Sweden Gram-positive Bacterial Infections Market Revenues & Volume, By Enteral, 2021- 2031F |
6.3.3 Sweden Gram-positive Bacterial Infections Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Sweden Gram-positive Bacterial Infections Market Revenues & Volume, By Others (Topical, Transdermal), 2021- 2031F |
6.4 Sweden Gram-positive Bacterial Infections Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Sweden Gram-positive Bacterial Infections Market Revenues & Volume, By Hospitals Pharmacies, 2021- 2031F |
6.4.3 Sweden Gram-positive Bacterial Infections Market Revenues & Volume, By Drug Stores and Retail Pharmacies, 2021- 2031F |
6.4.4 Sweden Gram-positive Bacterial Infections Market Revenues & Volume, By Others, 2021- 2031F |
7 Sweden Gram-positive Bacterial Infections Market Import-Export Trade Statistics |
7.1 Sweden Gram-positive Bacterial Infections Market Export to Major Countries |
7.2 Sweden Gram-positive Bacterial Infections Market Imports from Major Countries |
8 Sweden Gram-positive Bacterial Infections Market Key Performance Indicators |
8.1 Number of clinical trials focusing on gram-positive bacterial infections in Sweden |
8.2 Adoption rate of advanced diagnostic tools for detecting gram-positive bacterial infections |
8.3 Percentage of patients receiving timely and appropriate treatment for gram-positive bacterial infections |
9 Sweden Gram-positive Bacterial Infections Market - Opportunity Assessment |
9.1 Sweden Gram-positive Bacterial Infections Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Sweden Gram-positive Bacterial Infections Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.3 Sweden Gram-positive Bacterial Infections Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Sweden Gram-positive Bacterial Infections Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Sweden Gram-positive Bacterial Infections Market - Competitive Landscape |
10.1 Sweden Gram-positive Bacterial Infections Market Revenue Share, By Companies, 2024 |
10.2 Sweden Gram-positive Bacterial Infections Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |